Literature DB >> 7469207

Sporadic legionellosis in the United States: the first thousand cases.

A C England, D W Fraser, B D Plikaytis, T F Tsai, G Storch, C V Broome.   

Abstract

As of 30 September 1979, 1005 confirmed cases of sporadic legionellosis caused by Legionella pneumophila serogroups 1 to 4 in U.S. residents had been reported to the Centers for Disease Control; 19% were fatal. All but 2% of the 1005 cases were associated with pneumonia documented by chest radiograph. About 75% of the cases occurred in June through October. The risk of acquiring sporadic legionellosis was increased among males and persons 50 years or older; persons with renal disease necessitating dialysis or transplantation, with chronic bronchitis or emphysema, with diabetes mellitus, and with cancer (10 selected sites or types); persons who smoke; and persons being treated with immunosuppressive drugs. Increasing age and chronic bronchitis or emphysema were associated with increased risk of death. The sensitivity of culturing L. pneumophila from specimens positive by direct immunofluorescence was estimated to be 45%. The distribution of serogroups 1, 2, 3, and 4 of L. pneumophila in 57 fresh, not previously examined direct fluorescent antibody-positive specimens was 84%, 11%, 4%, and 2%, respectively; all 26 strains isolated from these specimens were of one of these four serogroups.

Entities:  

Mesh:

Year:  1981        PMID: 7469207     DOI: 10.7326/0003-4819-94-2-164

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  27 in total

1.  A pseudo community outbreak of legionnaires' disease on Merseyside; implications for investigation of suspected clusters.

Authors:  C M Regan; Q Syed; K Mutton; B Wiratunga
Journal:  J Epidemiol Community Health       Date:  2000-10       Impact factor: 3.710

2.  Sporadic cases of community acquired legionnaires' disease: an ecological study to identify new sources of contamination.

Authors:  D Che; B Decludt; C Campese; J C Desenclos
Journal:  J Epidemiol Community Health       Date:  2003-06       Impact factor: 3.710

3.  Variation in time and space of non-outbreak Legionnaires' disease in Scotland.

Authors:  R S Bhopal; R J Fallon
Journal:  Epidemiol Infect       Date:  1991-02       Impact factor: 2.451

Review 4.  Diagnosis of Legionella infection in Legionnaires' disease.

Authors:  J W Den Boer; E P F Yzerman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-12       Impact factor: 3.267

5.  Pinpointing clusters of apparently sporadic cases of Legionnaires' disease.

Authors:  R S Bhopal; P Diggle; B Rowlingson
Journal:  BMJ       Date:  1992-04-18

6.  Effect of immunosuppressive therapy on the clinical presentation of legionellosis.

Authors:  K Skogberg; P Ruutu; I Koivula; H Jousimies-Somer; V Valtonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

7.  Genetic, immunological, and cytotoxic comparisons of Legionella proteolytic activities.

Authors:  F D Quinn; M G Keen; L S Tompkins
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

8.  [Smoking and lower respiratory tract infection].

Authors:  R B Brown
Journal:  Infection       Date:  1987       Impact factor: 3.553

9.  Antibody-mediated enhancement of Legionella pneumophila-induced interleukin 1 activity.

Authors:  R H Widen; C A Newton; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Legionnaires' disease at a Dutch flower show: prognostic factors and impact of therapy.

Authors:  Kamilla D Lettinga; Annelies Verbon; Gerrit-Jan Weverling; Joop F P Schellekens; Jeroen W Den Boer; Ed P F Yzerman; Jacobus Prins; Wim G Boersma; Ruud J van Ketel; Jan M Prins; Peter Speelman
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.